Skip to NavigationSkip to content

c linical transparency

UK MPs call for greater action on clinical transparency and trial reporting

The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical trial sponsors to adequately report their findings is leading to a waste of resources and could pose a threat to public health.

The report builds upon the findings from the University of Oxford’s EBM DataLab, whose recently-launched EUTrialsTracker revealed that only 51.4% of 7,784 trials required to report their findings on the European Union clinical trials register (EUCTR) had done so.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches